PharmaTech Recalls Product Due to Contamination Risk
The company is voluntarily recalling liquid products due to possible Burkholderia cepacia contamination.
PharmaTech, LLC (Davie, FL) announced on August 8, 2016 that the company was voluntarily recalling all of its liquid products manufactured from Oct. 20, 2015–July 15, 2016. The recall is due to the potential risk for Burkholderia cepacia (B. cepacia) contamination in the recalled products.
Patients with compromised immune systems and patients with chronic lung conditions could be at risk of infection if they use products contaminated with B. cepacia, according to the company. The company, however, states in a press release that it has not received any complaints of contamination associated with the recalled lots. A list of recalled lots can be found here.
PharmaTech is notifying customers and distributors of the recall and is stating that consumers, pharmacies, and healthcare facilities should stop using the products immediately. Adverse events can be reported to FDA at www.fda.gov/medwatch/report.htm.
Source: FDA
Editor's Note: Pharmaceutical Technology magazine is not affiliated with the recall. All inquiries should be directed to PharmaTech, LLC.
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.
